GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (OTCPK:CHJTF) » Definitions » EBITDA Margin %

CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) EBITDA Margin % : 23.58% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. CSPC Pharmaceutical Group's EBITDA for the three months ended in Dec. 2023 was $251 Mil. CSPC Pharmaceutical Group's Revenue for the three months ended in Dec. 2023 was $1,062 Mil. Therefore, CSPC Pharmaceutical Group's EBITDA margin for the quarter that ended in Dec. 2023 was 23.58%.


CSPC Pharmaceutical Group EBITDA Margin % Historical Data

The historical data trend for CSPC Pharmaceutical Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group EBITDA Margin % Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.21 28.92 27.70 27.98 27.13

CSPC Pharmaceutical Group Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.81 22.17 23.76 24.85 23.58

Competitive Comparison of CSPC Pharmaceutical Group's EBITDA Margin %

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSPC Pharmaceutical Group's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's EBITDA Margin % falls into.



CSPC Pharmaceutical Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

CSPC Pharmaceutical Group's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=1195.031/4404.654
=27.13 %

CSPC Pharmaceutical Group's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=250.502/1062.3
=23.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CSPC Pharmaceutical Group  (OTCPK:CHJTF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


CSPC Pharmaceutical Group EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Business Description

Traded in Other Exchanges
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Headlines

From GuruFocus

Value Partners Classic Fund Comments on CSPC Pharmaceutical

By Vera Yuan Vera Yuan 07-29-2014